BioCardia, Inc. — Form 8-K
Filed September 21, 2026 · analyzed by the 8-K Agent
8-K
— Neutral
significance 12/100
What the filing says
BioCardia, Inc. (market cap ~$9.7M) filed Form 8-K on 2026-09-21 disclosing Item 8.01 (Other Events). The filing document itself contains no substantive narrative detail—only metadata, XBRL taxonomy files, and structural SEC filing information. No counterparties, dollar amounts, percentages, share counts, dates of material transactions, or business changes are specified in the text provided.
Why this rating
No material business event disclosed; filing is administrative disclosure with no quantified transaction details or operational impact stated.
Extracted items
See more from September 21, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.